Viewing Study NCT04377932


Ignite Creation Date: 2025-12-24 @ 10:00 PM
Ignite Modification Date: 2026-01-02 @ 11:58 AM
Study NCT ID: NCT04377932
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-17
First Post: 2020-05-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Sponsor: Baylor College of Medicine
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-08-08
Start Date Type: ACTUAL
Primary Completion Date: 2024-08-17
Primary Completion Date Type: ACTUAL
Completion Date: 2040-08-26
Completion Date Type: ESTIMATED
First Submit Date: 2020-05-04
First Submit QC Date: None
Study First Post Date: 2020-05-07
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-11-14
Last Update Post Date: 2025-11-17
Last Update Post Date Type: ESTIMATED